Total Payments
$789.07
2024 Payments
$34.48
Companies
13
Transactions
33
Medicare Patients
706
Medicare Billing
$53,987
Payment Breakdown by Category
Food & Beverage$789.07 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $789.07 | 33 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $230.24 | 13 | $0 (2021) |
| Horizon Pharma plc | $167.11 | 6 | $0 (2018) |
| Flexion Therapeutics, Inc. | $122.07 | 1 | $0 (2020) |
| BOSTON SCIENTIFIC CORPORATION | $58.46 | 1 | $0 (2018) |
| Ferring Pharmaceuticals Inc. | $43.27 | 3 | $0 (2018) |
| Amgen Inc. | $36.71 | 2 | $0 (2021) |
| Tactile Systems Technology Inc | $34.48 | 1 | $0 (2024) |
| Daiichi Sankyo Inc. | $20.06 | 1 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $18.68 | 1 | $0 (2020) |
| AbbVie Inc. | $16.40 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $34.48 | 1 | Tactile Systems Technology Inc ($34.48) |
| 2021 | $75.98 | 5 | Horizon Therapeutics plc ($26.31) |
| 2020 | $174.51 | 4 | Flexion Therapeutics, Inc. ($122.07) |
| 2019 | $190.23 | 10 | Horizon Therapeutics plc ($190.23) |
| 2018 | $236.81 | 8 | Horizon Pharma plc ($149.37) |
| 2017 | $77.06 | 5 | Ferring Pharmaceuticals Inc. ($29.02) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $34.48 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 10/29/2021 | Horizon Therapeutics plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: PENNSAID | ||||||
| 09/15/2021 | DePuy Synthes Sales Inc. | ORTHOVISC (Device), MONOVISC | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Sports Early Intervention | ||||||
| 05/27/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2021 | Horizon Therapeutics plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: PENNSAID | ||||||
| 03/11/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Bone Health | ||||||
| 09/10/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/18/2020 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Anemia | ||||||
| 03/28/2020 | Horizon Therapeutics plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: PENNSAID | ||||||
| 02/18/2020 | Flexion Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | In-kind items and services | $122.07 | General |
| Category: Musculoskeletal | ||||||
| 12/19/2019 | Horizon Therapeutics plc | VIMOVO (Drug), VIMOVO | Food and Beverage | In-kind items and services | $8.39 | General |
| Category: VIMOVO | ||||||
| 12/16/2019 | Horizon Therapeutics plc | — | Food and Beverage | In-kind items and services | $8.92 | General |
| 11/14/2019 | Horizon Therapeutics plc | VIMOVO (Drug), VIMOVO | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: VIMOVO | ||||||
| 11/14/2019 | Horizon Therapeutics plc | VIMOVO (Drug), VIMOVO | Food and Beverage | In-kind items and services | $0.51 | General |
| Category: VIMOVO | ||||||
| 10/29/2019 | Horizon Therapeutics plc | — | Food and Beverage | In-kind items and services | $4.41 | General |
| 09/10/2019 | Horizon Therapeutics plc | VIMOVO (Drug), VIMOVO | Food and Beverage | In-kind items and services | $10.01 | General |
| Category: VIMOVO | ||||||
| 07/08/2019 | Horizon Therapeutics plc | — | Food and Beverage | In-kind items and services | $6.83 | General |
| 04/05/2019 | Horizon Therapeutics plc | VIMOVO (Drug), VIMOVO | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: VIMOVO | ||||||
| 04/04/2019 | Horizon Therapeutics plc | — | Food and Beverage | In-kind items and services | $120.09 | General |
| 04/01/2019 | Horizon Therapeutics plc | VIMOVO (Drug), VIMOVO | Food and Beverage | In-kind items and services | $6.45 | General |
| Category: VIMOVO | ||||||
| 10/11/2018 | Horizon Pharma plc | PRIMARY CARE - DISEASE STATE (Drug) | Food and Beverage | Cash or cash equivalent | $115.82 | General |
| Category: NONE | ||||||
| 09/04/2018 | Horizon Pharma plc | VIMOVO (Drug), VIMOVO | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: VIMOVO | ||||||
| 09/04/2018 | Horizon Pharma plc | NO_PRODUCT (Drug) | Food and Beverage | In-kind items and services | $6.15 | General |
| Category: NONE | ||||||
| 07/06/2018 | Horizon Pharma plc | VIMOVO (Drug), VIMOVO | Food and Beverage | In-kind items and services | $4.82 | General |
| Category: VIMOVO | ||||||
| 06/01/2018 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: ORTHOPEDICS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 9 | 237 | 1,542 | $77,897 | $22,296 |
| 2021 | 12 | 329 | 443 | $62,164 | $22,951 |
| 2020 | 7 | 140 | 174 | $27,696 | $8,741 |
Total Patients
706
Total Services
2,159
Medicare Billing
$53,987
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J7325 | Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | Office | 2022 | 16 | 1,056 | $36,960 | $8,415 | 22.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 56 | 79 | $12,561 | $4,488 | 35.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 42 | 61 | $10,640 | $3,352 | 31.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 30 | 30 | $7,140 | $2,328 | 32.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 18 | $4,248 | $1,695 | 39.9% |
| 73564 | X-ray of knee, 4 or more views | Office | 2022 | 22 | 30 | $3,030 | $1,008 | 33.3% |
| 72110 | X-ray of lower and sacral spine, minimum of 4 views | Office | 2022 | 13 | 13 | $1,573 | $432.32 | 27.5% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2022 | 11 | 14 | $1,022 | $374.22 | 36.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 32 | 241 | $723.00 | $203.47 | 28.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 80 | 117 | $18,682 | $8,111 | 43.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 50 | 50 | $11,900 | $3,967 | 33.3% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 38 | 56 | $10,240 | $3,296 | 32.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $4,719 | $1,671 | 35.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 18 | $4,248 | $1,669 | 39.3% |
| 73564 | X-ray of knee, 4 or more views | Office | 2021 | 34 | 43 | $4,192 | $1,461 | 34.8% |
| 72110 | X-ray of lower and sacral spine, minimum of 4 views | Office | 2021 | 20 | 20 | $2,420 | $721.82 | 29.8% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2021 | 18 | 22 | $1,584 | $618.24 | 39.0% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2021 | 11 | 18 | $1,278 | $405.85 | 31.8% |
| 73502 | X-ray of hip with pelvis, 2-3 views | Office | 2021 | 12 | 12 | $1,128 | $400.10 | 35.5% |
| 73610 | X-ray of ankle, minimum of 3 views | Office | 2021 | 11 | 16 | $1,194 | $368.16 | 30.8% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2021 | 27 | 58 | $580.00 | $261.94 | 45.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 42 | 57 | $9,063 | $2,895 | 31.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 22 | 22 | $5,236 | $1,593 | 30.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 15 | 17 | $4,012 | $1,368 | 34.1% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 16 | 21 | $4,000 | $1,169 | 29.2% |
About Mohammad Sidiquee
Mohammad Sidiquee is a Sports Medicine healthcare provider based in Spring, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2010. The National Provider Identifier (NPI) number assigned to this provider is 1023329190.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mohammad Sidiquee has received a total of $789.07 in payments from pharmaceutical and medical device companies, with $34.48 received in 2024. These payments were reported across 33 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($789.07).
As a Medicare-enrolled provider, Sidiquee has provided services to 706 Medicare beneficiaries, totaling 2,159 services with total Medicare billing of $53,987. Data is available for 3 years (2020–2022), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Sports Medicine
- Location Spring, TX
- Active Since 06/23/2010
- Last Updated 07/21/2022
- Taxonomy Code 207QS0010X
- Entity Type Individual
- NPI Number 1023329190
Products in Payments
- Zilretta (Drug) $122.07
- PRIMARY CARE - DISEASE STATE (Drug) $115.82
- VIMOVO (Drug) $86.76
- GENERAL PAIN MANAGEMENT (Device) $58.46
- PENNSAID (Drug) $48.37
- EUFLEXXA (Device) $43.27
- Flexitouch Plus (Device) $34.48
- INJECTAFER (Drug) $20.06
- Prolia (Biological) $19.08
- FARXIGA (Drug) $18.68
- EVENITY (Biological) $17.63
- VRAYLAR (Drug) $16.40
- ORTHOVISC (Device) $15.64
- Belviq (Drug) $14.73
- VYVANSE (Drug) $11.22
- NO_PRODUCT (Drug) $6.15
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.